Location: Virtual | 10:00 - 11:00 a.m. ET*
ISO 22441 requires facilities to implement measures for the control and monitoring of a Vaporized Hydrogen Peroxide (VHP™) sterilizer. Compared to conventional sterilization methods, VHP is relatively new in the medical device, pharmaceutical and biotechnology industries.
This webinar will provide guidance on how to meet ISO 22441 requirements for VHP sterilization. Additionally, we will introduce and explain the new, standard independent monitoring feature for STERIS VHP LTS-V Low Temperature Sterilizers.
Patient safety is always at the forefront when requirements are established, and improving control and monitoring integrity supports that goal for VHP sterilizer equipment.
* Please note that the webinar broadcast time is listed in the Eastern Time Zone (ET). If necessary, be sure to convert to your local time zone.
Thank you for your interest, but the broadcast date for this webinar has passed. Please refer to our Events page to view upcoming events.
Meet the Presenters
Juha Mattila | Director, Sterilization Technologies
Juha has over two decades of experience in pharmaceutical, research and biosafety technologies. He manages the STERIS Life Sciences portfolio of products for Vaporized Hydrogen Peroxide (VHP) and steam sterilization, material transfer biodecontamination technologies and water for injection and pure steam generation systems. He holds a master’s degree in business informatics and a bachelor’s degree in heating, ventilation and air conditioning (HVAC) and process engineering.
In addition to being an active member of the Parenteral Drug Association (PDA), the International Society for Pharmaceutical Engineering (ISPE) and the Finnish Biosafety Network, Juha has authored several technical articles and spoken at many industry events. He also contributes to the International Organization for Standardization (ISO), the European Committee for Standardization (CEN) and the British Standards Institution (BSI) work groups considering these technologies.
Juha provided commentary through the PDA for the European Union (EU) Good Manufacturing Practices (GMP) Annex 1 draft and participated in the PDA EU GMP Annex 1 Workshop.